v3.26.1
Related parties
6 Months Ended
Jun. 30, 2026
Related party transactions [abstract]  
Related parties Related parties
Related party transactions as of 30 June 2026 are as follows:
Purchases /
interest
Sold serviceReceivables
Payables/
borrowings
Alvogen Lux Holdings S.à r.l. – Sister company (a)
1,473 — — 1,434 
Aztiq Consulting ehf. – Sister company90 — — 85 
Flóki-Art ehf. - Sister company— — — 411 
Aztiq UK Ltd. - Sister company132 — 82 
Alvogen Finance B.V. - Sister Company731 — — — 
Lotus Pharmaceuticals Co. Ltd. - Sister company— 92 90 — 
Alvogen Inc. - Sister company— 92 89 656 
Entity under common influence/control (b)
39,750 
Klettagarðar 6 ehf. - Sister company (c)
673 915 2,898 
L41 ehf. - Sister company— — 
Flóki Invest ehf - Sister company778 — — 799 
Alvogen Spain SL - Sister company— — — 15 
Norwich Clinical Services Ltd - Sister company761 — — 597 
Hlíðarvegur 20 ehf.21 — — — 
Fasteignafélagið Eyjólfur ehf - Sister company8,158 — — 95,858 
Flóki fasteignir ehf. - Sister company2,640 — — 13,703 
15,461 40,849 179 116,540 
(a)The full amount of purchased service relates to royalty expense.
(b)During the six months ended 30 June 2026, the Group recognized $39.8 million of License and other revenue under a strategic licensing and commercialization arrangement with an entity under common control/influence (see Note 5).
(c)The receivable is classified within Other long-term assets in the Consolidated Statement of Financial Position.


Related party transactions for the six months ended 30 June 2025 and as of 31 December 2025 are as follows:
30 June 202531 December 2025
Purchased service /
interest
Sold serviceReceivablesPayables/
borrowings
Alvogen Lux Holdings S.à r.l. – Sister company (a)
3,925 — — — 
ATP Holdings ehf. - Sister company210 32 — 125 
Aztiq Consulting ehf. – Sister company— — — 
Flóki-Art ehf. - Sister company— — — 430 
Alvogen Iceland ehf. - Sister company— — — 
Alvogen ehf. - Sister company— 22 — 
Alvogen UK - Sister company93 — — 28 
Alvogen Finance B.V. - Sister Company415 — — — 
Lotus Pharmaceuticals Co. Ltd. - Sister company— — — 
Alvogen Inc. - Sister company37 656 
Klettagarðar 6 ehf. (c)— — 4,037 2,923 
Adalvo Limited - Sister company (b)
621 184 
L41 ehf. - Sister company36 — — 
Flóki Invest ehf - Sister company516 — — 276 
Alvogen Malta Sh. Services - Sister company13 — — — 
Alvogen Spain SL - Sister company— — — 16 
Norwich Clinical Services Ltd - Sister company738 — — 605 
Hlíðarvegur 20 ehf.18 — — — 
Fasteignafélagið Eyjólfur ehf - Sister company7,707 — — 96,304 
Flóki fasteignir ehf. - Sister company1,324 — — 15,838 
15,660 241 4,042 117,207 
(a)The full amount of purchased service relates to royalty expenses.
(b)No longer a related party at 31 December 2025.
(c)The receivable is classified within Other long-term assets in the Consolidated Statement of Financial Position.